Company Monitoring Page for Clovis-Oncology

latest headlines for company on cafepharma

Clovis shuts down cancer drug, will reduce staff by 35%
BioPharma Dive
Sat, 05/7/16 - 01:17 pm
Tags:
Clovis Oncology, rociletinib, layoffs
Are Analysts Realistic on Clovis Oncology Now?
24/7 Wall St
Sun, 04/17/16 - 11:18 am
Tags:
Clovis Oncology, rociletinib
Clovis Lung Cancer Drug Trashed at FDA Panel, CEO Exit Next?
TheStreet.com
Tue, 04/12/16 - 03:43 pm
Tags:
Clovis Oncology, FDA, advisory panels, rociletinib, Pat Mahaffy
FDA staff questions Clovis drug's benefit over current treatments
Yahoo/Reuters
Fri, 04/8/16 - 11:08 am
Tags:
FDA, Clovis Oncology, rociletinib, non-small cell lung cancer
Struggling Clovis to once again chase FDA favor for would-be Tagrisso competitor
BioPharma Dive
Tue, 02/16/16 - 10:26 am
Tags:
Clovis Oncology, FDA, Tagrisso, rociletinib
3 Upcoming FDA Decisions We're Most Excited About
Motley Fool
Sat, 02/13/16 - 09:25 am
Tags:
FDA, Acadia, Intercept Pharma, Clovis Oncology, Nuplazid, OCA, rociletinib
Clovis Oncology Issues Update On Rociletinib, Will Meet With FDA On April 12
Yahoo/Benzinga
Fri, 02/12/16 - 04:25 pm
Tags:
Clovis Oncology, rociletinib, FDA, non-small cell lung cancer
4 Pharmaceutical Stocks With Big Catalysts Pending in 2016
24/7 Wall St
Fri, 01/8/16 - 09:43 am
Tags:
Jazz Pharmaceuticals, Defibrotide, Clovis Oncology, rociletinib, Insys, Dronabinol, Gilead Sciences, F/TAF
10 Biotechs Short Sellers Are Betting Against
Yahoo/Benzinga
Wed, 12/30/15 - 10:40 am
Tags:
biotech, Global Blood Therapeutics, Clovis Oncology, Epizyme, Bluebird Bio, Puma Biotechnology, Tokai, MannKind, Myriad Genetics, Orexigan, KaloBios
Boehringer grabs 'breakthrough,' plots pivotal trials for rival to AstraZeneca, Clovis
Fierce Biotech
Mon, 12/21/15 - 10:50 am
Tags:
Boehringer Ingelheim, breakthrough therapies, BI1482694, AstraZeneca, Clovis Oncology, non-small cell lung cancer
Clovis Oncology: The Revenant?
Investopedia
Wed, 12/16/15 - 07:59 pm
Tags:
rociletinib, Clovis Oncology
4 Key FDA Decisions Expected By Year End
24/7 Wall St
Sun, 11/29/15 - 12:43 pm
Tags:
FDA, Achillion, hepatitis C, Biocryst, OPuS-2, BCX4161, Tetraphase Pharmaceuticals, Lucitanib, Clovis Oncology
6 BioHealth Movers That Now Cannot Be Ignored
24/7 Wall St
Sun, 11/22/15 - 01:33 pm
Tags:
Clovis Oncology, KaloBios, Celladon, Sarepta Therapeutics, Zafgen, Valeant Pharmaceuticals
Clovis Oncology's Loss Could Be a Win for AstraZeneca
Motley Fool
Thu, 11/19/15 - 09:47 am
Tags:
Clovis Oncology, AstraZeneca, rociletinib, Tagrisso, non-small cell lung cancer
The FDA asked this company for some data and now its stock is down 72%
Yahoo/Business Insider
Mon, 11/16/15 - 03:31 pm
Tags:
Clovis Oncology, FDA, rociletinib
Clovis Oncology Gets Hit Hard: FDA Delays Approval
Bidness, ETC
Mon, 11/16/15 - 09:18 am
Tags:
Clovis Oncology, FDA, rociletinib, non-small cell lung cancer
3 Cancer Companies to Watch Closely in 2016
Motley Fool
Tue, 10/20/15 - 10:00 am
Tags:
cancer, Celldex, Medivation, Clovis Oncology, rociletinib, talazoparib, Rintega
Biogen And Four Other Biotech Stocks Worth Watching
Forbes
Sat, 10/10/15 - 09:12 am
Tags:
Biogen, Esperion, Zafgen, Clovis Oncology, Portola
Clovis Oncology Inc Giving AstraZeneca plc A Hard Time In Cancer
Bidness, ETC
Fri, 10/2/15 - 09:11 am
Tags:
Clovis Oncology, AstraZeneca, rociletinib, AZD9291, non-small cell lung cancer
Racing AstraZeneca, Clovis gets a speedy FDA review for its lung cancer drug
Fierce Biotech
Wed, 09/30/15 - 04:43 pm
Tags:
AstraZeneca, Clovis Oncology, FDA, rociletinib, lung cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.